LATISSE® (bimatoprost ophthalmic solution) 0.03% is the first and only science-based prescription treatment approved by the U.S. Food and Drug Administration (FDA) for hypotrichosis that is used to grow eyelashes, making them longer, thicker and darker.
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
LATISSE® solution is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE® should not be applied to the lower eyelashes as there is a potential for hair growth to occur in areas where LATISSE® comes in repeated contact with skin surfaces, and only the sterile applicators packaged with LATISSE® should be used to apply the treatment. Don’t allow the tip of the bottle or applicator to contact surrounding structures, fingers, or any other unintended surface in order to avoid contamination by common bacteria known to cause infections. Contact lenses should be removed prior to application of LATISSE® and may be reinserted 15 minutes following its administration.
How was LATISSE® studied?
LATISSE® solution was clinically tested in a Phase III study. Patients were randomly assigned to apply treatment with LATISSE® or vehicle to both upper eyelids, at the base of the lashes, once daily for 16 weeks. The primary efficacy endpoint was overall eyelash prominence at the end of the 16-week treatment period as measured by a ≥1-grade improvement on a 4-point Global Eyelash Assessment Scale. Secondary efficacy endpoints were eyelash length, thickness, and darkness. All of the endpoints in the LATISSE® pivotal trial were met. By the end of the 16-week treatment period, patients treated with LATISSE® experienced statistically significant greater improvement (p < 0.0001="" for="" each="" endpoint)="" than="" those="" in="" the="" placebo="" group="" in="" the="" measurements="" of="" eyelash="" prominence,="" length,="" thickness="" and="">
How does LATISSE® work?
Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase; and second, it increases the number of hairs in this growth phase. Bimatoprost is the active pharmaceutical ingredient in LATISSE®.
Important Information About LATISSE®
LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.